Published in BMJ on July 16, 1988
Effect of flosequinan on exercise capacity and symptoms in severe heart failure. Br Heart J (1989) 0.93
The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure. Br J Clin Pharmacol (1990) 0.78
The effects of flosequinan on regional blood flow in normal man. Br J Clin Pharmacol (1991) 0.77
Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers. Br J Clin Pharmacol (1992) 0.76
Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure. Br J Clin Pharmacol (1993) 0.75
A comparison of the effects of flosequinan, a new vasodilator, and propranolol on sub-maximal exercise in healthy volunteers. Br J Clin Pharmacol (1989) 0.75
Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study. Heart Vessels (1992) 0.75
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med (1985) 2.22
Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med (1980) 1.37
Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure. Br Heart J (1986) 1.19
The pharmacokinetics and haemodynamics of BTS 49 465 and its major metabolite in healthy volunteers. Eur J Clin Pharmacol (1985) 1.15
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. Br Med J (Clin Res Ed) (1985) 1.12
Do vasodilators prolong life in heart failure? N Engl J Med (1987) 1.09
Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure. Lancet (1984) 1.08
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity. Circulation (1986) 0.96
An automated method to measure monoamines and metabolites using elevated temperature reversed phase HPLC with electrochemical detection. Application to striatal dopamine and hippocampal serotonin turnover. J Pharmacol Methods (1984) 0.87
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet (1988) 4.07
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17
Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation (2000) 2.90
Open access. BMJ (1995) 2.76
Comparison of results from a cardiac ambulance manned by medical or non-medical personnel. Lancet (1977) 2.75
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet (1990) 2.70
Follow-up of emergency ambulance calls in Nottingham: implications for coronary ambulance servie. Br Med J (1975) 2.66
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Randomised trial of a mobile coronary care unit for emergency calls. Br Med J (1978) 2.35
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) (1981) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Electrocardiogram interpretation as a basis for thrombolysis. J R Coll Physicians Lond (1998) 2.21
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Mode of referral to hospital of patients with heart attacks: relevance to home care and special ambulance services. Br Med J (1976) 2.04
Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes (1978) 2.04
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Advanced training for ambulance crews: implications from 403 consecutive patients with cardiac arrest managed by crews with simple training. Br Med J (Clin Res Ed) (1987) 1.92
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation (1996) 1.86
Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) (1981) 1.86
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Diagnostic criteria for myocardial infarction. Br J Hosp Med (1981) 1.82
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol (1993) 1.80
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Simple training programme for ambulance personnel in the management of cardiac arrest in the community. Br Med J (Clin Res Ed) (1985) 1.74
Neurological presentation of bacterial endocarditis. Br Med J (1967) 1.70
Differences in drug treatment of chronic heart failure between European countries. Eur Heart J (1999) 1.63
The National Service Framework for coronary heart disease: the emperor's new clothes. J R Coll Physicians Lond (2000) 1.60
Comparison of mortality of patients with heart attacks admitted to a coronary care unit and an ordinary medical ward. Br Med J (1977) 1.57
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
The origin and secretion of pancreatic juice bicarbonate. J Physiol (1970) 1.53
The health of the nation's research and development. BMJ (1993) 1.52
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register. QJM (1995) 1.47
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. Br Med J (1979) 1.41
The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J (1995) 1.41
The limited potential of special ambulance services in the management of cardiac arrest. Br Heart J (1990) 1.39
Captopril therapy for heart failure. A placebo controlled study. Lancet (1982) 1.39
Cardiovascular control in diabetes mellitus. Br Med J (1975) 1.34
Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res (1967) 1.32
Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry (1976) 1.31
Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31
Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31
Nature of the transferable factor which causes abnormal platelet behaviour in vascular disease. Lancet (1967) 1.27
Comparison of mobilization after two and nine days in uncomplicated myocardial infarction. Br Med J (1974) 1.27
Cardiovascular reflex responses to apnoeic face immersion and mental stress in diabetic subjects. Cardiovasc Res (1976) 1.27
Survey of general practitioners' attitudes to management of patients with heart attacks. Br Med J (1975) 1.26
Diabetic autonomic neuropathy. Diabetes (1978) 1.25
Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials. Br Med J (Clin Res Ed) (1982) 1.25
Influence of ambulance crew's length of experience on the outcome of out-of-hospital cardiac arrest. Eur Heart J (1999) 1.24
Legionnaires' disease: a clinical description of thirteen cases. Br J Dis Chest (1979) 1.23
Effect of oral contraceptive agents on platelets and plasma-phospholipids. Lancet (1968) 1.23
A non-invasive method for measuring cardiac output: the effect of Christmas lunch. Lancet (1987) 1.22
Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure. Br Heart J (1986) 1.19
Importance of patient selection in evaluating a cardiac ambulance service. Br Med J (1976) 1.19
Coronary artery bypass grafting for the reduction of mortality: an analysis of the trials. Br Med J (Clin Res Ed) (1984) 1.17
Geographical distribution of cardiac arrest in Nottinghamshire. Resuscitation (2001) 1.16
The pharmacokinetics and haemodynamics of BTS 49 465 and its major metabolite in healthy volunteers. Eur J Clin Pharmacol (1985) 1.15
Effect of glass contact on the electrophoretic mobility of human blood platelets. Nature (1966) 1.14
Telephone consultations. Br J Gen Pract (1992) 1.13
Platelet studies in patients with coronary artery disease and in their relatives. Br Heart J (1972) 1.12
Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet (1986) 1.12
A generation effect with numbers rather than words. Mem Cognit (1984) 1.11
Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure. Lancet (1984) 1.08
Implication of prescriptions for nitrates: 7 year follow up of patients treated for angina in general practice. Br Heart J (1994) 1.08
The use of beta blockers for the reduction of mortality after myocardial infarction. Eur Heart J (1981) 1.07
Cardiovascular responses to lower body negative pressure in normal subjects and in patients with diabetes mellitus. Cardiovasc Res (1979) 1.07
Comparison of the SF-36 health survey questionnaire with the Nottingham Health Profile in long-term survivors of a myocardial infarction. J Public Health Med (2000) 1.07
The appropriateness of the use of cardiovascular procedures. British versus U.S. perspectives. Int J Technol Assess Health Care (1993) 1.06